BUDAPEST, Hungary and CAMBRIDGE, Massachusetts, August 19, 2010 /PRNewswire/ --
- Compound Registration, Structure Search and Computed Properties Rolled Out
ChemAxon, a leading provider of chemistry software for life sciences, announced today that they have entered into an agreement with the Broad Institute of Harvard and MIT, which will license ChemAxon's platform, discovery toolkits and desktop applications for institute-wide use. Broad will support their legacy small molecule registration system and other functionality across their Chemical Biology Platform with ChemAxon's technology.
In addition to ChemAxon's discovery and desktop tools, the Broad Institute has already updated their core technology for archiving small molecules by deploying the JChem platform toolkit within their existing system.
"This adoption is a part of our strategy to provide our scientists in the Chemical Biology Platform with the most modern and capable tools to accelerate our research," said Michael Foley, Director of the Broad's Chemical Biology Platform. "The extensive capabilities of the ChemAxon software support our ongoing efforts to build and apply state of the art facilities to support our work."
The evaluation and deployment is to be presented during ChemAxon's User Group Meeting being held in Boston's Omni Parker House, September 14-15, the complete program is here: http://www.chemaxon.com/events/2010-us-ugm/
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication. For more information please visit http://www.chemaxon.com.
SOURCE ChemAxon Ltd.